Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
All LSBio Custom kits have been predesigned and all necessary components, including antibodies and standards have been identified. Upon receiving a custom kit order, the kit will be assembled and quality control tested before being shipped out. Kit assembly and testing typically takes 4 to 6 weeks. In most cases the final kit is based on the Sandwich assay principle, with a few being Competitive EIA based. Specifications such as Range, Sensitivity, and Precision are defined upon completion. In the event that the custom kit cannot be successfully developed with 6 weeks of the order date, the customer will be notified and the order canceled at no cost.
IMP-3 / IGF2BP3
LS-F44966 is a 96-well enzyme-linked immunosorbent assay (ELISA) for the Quantitative detection of Guinea pig IMP-3 / IGF2BP3. It is based upon a Custom assay principle and can be used to detect levels of IMP-3 / IGF2BP3 as low as 37.5 picograms per milliliter.
IGF2BP3 ElisaKit, CT98 ElisaKit, IGF II mRNA binding protein 3 ElisaKit, IMP-3 ElisaKit, KOC1 ElisaKit, IGF-II mRNA-binding protein 3 ElisaKit, IGF2 mRNA-binding protein 3 ElisaKit, VICKZ family member 3 ElisaKit, Cancer/testis antigen 98 ElisaKit, HKOC ElisaKit, VICKZ3 ElisaKit
RNA-binding factor that may recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells.